Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank86
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-15.95M
↑ 16% vs avg
Percentile
P86
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-19.10M
Historical baseline
PeriodValueYoY Change
TTM$-15.95M+17.6%
2024$-19.36M+3.4%
2023$-20.03M+5.4%
2022$-21.17M+4.8%
2021$-22.25M-152.1%
2020$-8.82M+53.3%
2019$-18.88M+5.5%
2018$-19.99M+4.3%
2017$-20.88M+11.8%
2016$-23.67M-